It’s bad enough that blacks are already more likely than whites to die from HIV/AIDS. But a drug company’s scheme to put profits ahead of lives only compounds the anguish of targeted communities and amplifies cries for justice.
It’s an absolute outrage. We believe pharmaceutical giant Gilead Sciences knew its popular and hugely profitable HIV/AIDS drugs were harmful but purposely delayed releasing safer versions. Company executives didn’t see patients as people — they saw them only as dollar signs. That is why I have joined with co-counsels at the Hilliard Martinez Gonzales and Morgan & Morgan law firms to file a federal lawsuit against Gilead.
Continue reading Drug Maker Puts Profits Ahead of People of Color – by Ben Crump
After the presents have been opened and our belly’s are put to rest,
Mike Green, co-founder of ScaleUp Partners, is passionate about competitiveness and moving a 1% needle that has never been moved. All black-owned businesses today produce less than 1% of GDP and virtually no job growth. That 1% for the African-American sector has never been breached in the history of this nation. Combined with Hispanic businesses, the number is less than 4%. By mid-century that will mean 42% of the US population is producing 4% of its business productivity. That equation undermines America’s global competitiveness.